The Surgical Site Infection (SSI) market encompasses the range of products, services, and technologies aimed at preventing, diagnosing, and treating infections that occur at or near the surgical incision site within 30 days of surgery (or within one year if an implant is placed). This market includes antiseptics, antibiotics, advanced wound care products, diagnostic tools, sterilization equipment, and various surgical instruments designed to minimize infection risk. It also covers the development and implementation of infection control protocols, surveillance systems, and educational programs to reduce the incidence of SSIs, which are significant contributors to post-surgical morbidity and healthcare costs.